The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for adolescents and adults with severe asthma characterized by an eosinophilic phenotype. 1 ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

The new asthma treatment that could ‘transform lives’ - The injection is recommended as an additional maintenance treatment for patients over 12 when usual medications have not proven effective enough ...

Monthly monoclonal antibody injection tezepelumab is so effective in patients with severe asthma, half are able to stop daily steroid tablets.

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

New research has found that drinking camel milk can reduce the severity of asthma caused by house dust mites, a major trigger. While the research is still in the early stages, it opens the door to ...

A study has found that urban areas with more forests tend to have fewer asthma-related medical visits. Analysis suggests that ...